• <a fr-original-style="" href="https://www.ft.com/content/607d8b12-2447-42e2-a6dd-e9123016e81b" rel="noopener noreferrer" style="color: rgb(9, 9, 9); text-decoration: none; background-color: transparent; outline: none; cursor: pointer; transition: color 0.3s ease 0s; touch-action: manipulation; user-select: auto; box-sizing: border-box;" target="_blank">US activist investor Jeff Ubben</a> has taken a $500 million stake in Bayer through his firm Inclusive Capital Partners, the San Francisco-based firm announced on Monday. The investment amounts to almost 1% of the German pharmaceutical and biotechnology company that is still reeling from litigation over its weedkiller Roundup and years of shareholder discontent.<img src="https://images.aposto.com/2023/0/1/1673292894622.png" style="display: block; float: none; vertical-align: top; margin: 5px auto; text-align: center; width: 100%; max-width: 550px; border-style: none; position: relative; cursor: pointer; padding: 0px 1px; box-sizing: border-box;" ratio="1.79" width="550" alt="Jeff Ubben" fr-original-style="display: block; float: none; vertical-align: top; margin: 5px auto; text-align: center; width: 100%; max-width: 550px;" fr-original-class="fr-draggable">via FT<ul fr-original-style="padding-inline-start: 20px;" style="padding-inline-start: 20px; margin-top: 0px; margin-bottom: 1em; list-style-position: inside; box-sizing: border-box;"><li fr-original-style="" style="box-sizing: border-box;">Zoom out: Bayer is looking for a new leader to replace chief executive Werner Baumann, who is due to leave his post in 2024, the Financial Times reported. Baumann has been heavily criticized by shareholders for his ill-fated decision in 2016 to acquire seed maker Monsanto for $63 billion, the deal that brought Roundup under Bayer’s ownership.</li></ul>

Jeff Ubben ile ilgili hikayeler